In this study, the expression of YWHAE-NTRK3 induced sarcomas at 40% penetrance, whereas that of four other fusions, namely PPFIBP1-NTRK3, PAK2-RAF1, GAB1-ABL1 and wild-type ERAS, did not. Here, NTRK3 is linked to sarcoma.